Genextra S.p.a. - Net Worth and Insider Trading
Genextra S.p.a. Net Worth
The estimated net worth of Genextra S.p.a. is at least $76 Million dollars as of 2024-11-13. Genextra S.p.a. is the 10% Owner of Intercept Pharmaceuticals Inc and owns about 4,000,000 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $76 Million. Details can be seen in Genextra S.p.a.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Genextra S.p.a. has not made any transactions after 2020-08-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Genextra S.p.a.
Genextra S.p.a. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Genextra S.p.a. owns 1 companies in total, including Intercept Pharmaceuticals Inc (ICPT) .
Click here to see the complete history of Genextra S.p.a.’s form 4 insider trades.
Insider Ownership Summary of Genextra S.p.a.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ICPT | Intercept Pharmaceuticals Inc | 2020-08-17 | 10 percent owner |
Genextra S.p.a. Latest Holdings Summary
Genextra S.p.a. currently owns a total of 1 stock. Genextra S.p.a. owns 4,000,000 shares of Intercept Pharmaceuticals Inc (ICPT) as of August 17, 2020, with a value of $76 Million.
Latest Holdings of Genextra S.p.a.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ICPT | Intercept Pharmaceuticals Inc | 2020-08-17 | 4,000,000 | 19.00 | 76,000,000 |
Holding Weightings of Genextra S.p.a.
Genextra S.p.a. Form 4 Trading Tracker
According to the SEC Form 4 filings, Genextra S.p.a. has made a total of 2 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 1,500,000 shares on August 17, 2020, which brought Genextra S.p.a. around $71 Million.
Insider Trading History of Genextra S.p.a.
- 1
Genextra S.p.a. Trading Performance
GuruFocus tracks the stock performance after each of Genextra S.p.a.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Genextra S.p.a. is 36.02%. GuruFocus also compares Genextra S.p.a.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Genextra S.p.a. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Genextra S.p.a.'s insider trading performs compared to the benchmark.
Performance of Genextra S.p.a.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.99 | | | | | |
| Relative Return to S&P 500(%) | 0.75 | | | | | |
Genextra S.p.a. Ownership Network
Ownership Network List of Genextra S.p.a.
Ownership Network Relation of Genextra S.p.a.
Genextra S.p.a. Owned Company Details
What does Intercept Pharmaceuticals Inc do?
Who are the key executives at Intercept Pharmaceuticals Inc?
Genextra S.p.a. is the 10 percent owner of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and Chief Accounting Officer Rocco Venezia .
Intercept Pharmaceuticals Inc (ICPT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intercept Pharmaceuticals Inc Insider Transactions
Genextra S.p.a. Mailing Address
Above is the net worth, insider trading, and ownership report for Genextra S.p.a.. You might contact Genextra S.p.a. via mailing address: Via G. De Grassi, 11, Milan L6 20123.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
